>
网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
进展期胃癌患者行术前动脉介入化疗对肝脏微环境的影响
作者:周亮1  姚学权2  陈彻2  吴晓宇2  曹勤洪2  田君1  刘福坤2 
单位:1. 南京中医药大学 第一临床医学院, 江苏 南京 210029;
2. 江苏省中医院 消化肿瘤外科, 江苏 南京 210029
关键词:进展期胃癌 术前动脉介入化疗 静脉化疗 肝脏微环境 
分类号:R735.2;R453
出版年·卷·期(页码):2013·32·第六期(669-673)
摘要:

目的:观察进展期胃癌患者行新辅助化疗后的肝脏微环境的变化,评估术前动脉介入化疗的安全性。方法:收集小于70岁的胃癌患者60例,随机入组分为对照组、术前动脉介入化疗组和术前静脉化疗组,入院后常规检查肝功能,化疗后第1、3、7天抽取外周血了解化疗药物对肝脏功能的影响,术中收集正常肝组织观察术前新辅助化疗对肝脏结构的改变。结果:与术前静脉化疗组相比较,术前动脉介入化疗组光镜及电镜下肝脏细胞结构变化无显著差异,两组肝功能均在正常范围内;治疗组与对照组相比较,肝脏细胞结构发生变化,治疗后肝功能轻度异常。结论:术前动脉介入化疗后,患者肝功能及肝脏微结构无明显异常。

Objective: To study the changes of liver microenvironment in patients with gastric cancer after preoperative regional artery chemotherapy, evaluate the safety of preoperative arterial interventional chemotherapy. Methods: Sixty patients with gastric cancer were collected, which less than 70-year-old. Patients were divided into control group, preoperative regional artery chemotherapy group and preoperative intravenous chemotherapy group, during the surgery we collected gastric carcinoma tissues and normal liver tissue. The changes of cancer tissue and the liver structure were observed. The expressions of C-Met/HGF were detected. Implementation chemotherapy of the first, third and seventh days, peripheral venous blood was respectively collected, which in order to understand the effects of chemotherapy drugs on liver function. Results: By comparison to preoperative intravenous chemotherapy group, in the preoperative regional artery chemotherapy group, tumor necrosis was obviously,the liver structure changes had no significant differences under the light microscope and electron microscope, liver functions were within the normal ranges. The treatment group compared with control group, liver cell structure changed, mild abnormal liver function after treatment. Conclusion: Patients with preoperative arterial interventional chemotherapy have no obvious abnormal liver function and liver microstructure.

参考文献:

[1] 路平,王舒宝,袁媛,等.胃癌术前动脉栓塞化疗的临床及病理学研究[J].中华医学杂志,1996,76:146.
[2] 金巨光,赵忠春,徐克,等.进行期胃癌术前经动脉化疗栓塞的临床及病理学研究[J].临床医学影像杂志,1996,7:86.
[3] 刘福坤,陈忠豪,祁晓平,等.胃癌术前介入治疗后血管变化与癌组织坏死的关系[J].华人消化杂志,1998,6(8):686-688.
[4] 刘福坤,陈忠豪,曹建民.胃癌术前介入治疗的临床和病理观察(附250例报告)[J].南京大学学报:自然科学版,1998,34(2):167-171.
[5] LARREY D.Epidemiology and individual susceptibility to adverse drug reactions affecting the liver[J].Semin Liver Dis,2002,22(2):145-156.
[6] JIANG W G,HALLETT M B,PUNTIS M C A.Hepatocyte growth factor/scatter factor,liver regeneration and cancer metastasis[J].Br J Surg,1993,80(12):1368-1373.
[7] TAGUCHI T.Theory and practice of chemotherapy by arterial infusion: the importance of pharmacokinetic in research[J].Gan To Kagaku Ryoho,1994,11:1717.
[8] 詹文华.胃癌联合脏器切除术的合理选择及应用[J].中国实用外科杂志,2001,21(7):398-399.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 412000 位访问者


copyright ©《东南大学学报(医学版)》编辑部
联系电话:025-83272481 83272483
电子邮件:
bjb@pub.seu.edu.cn

苏ICP备09058364